Lisa E. Vaughan

ORCID: 0000-0002-5159-7738 · 5 papers in corpus
2020
·doi:10.1097/ogx.0000000000000758

(Abstracted from Acta Obstet Gynecol Scand 2019;98:1341–1350) Animal models suggest that increased uterine prolactin concentration is a risk factor for adenomyosis. Prolactin is produced in the human endometrium, myometrium, and the pituita…

rct 2019
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2018.10.032

BACKGROUND: Uterine leiomyomas (fibroid tumors) cause considerable symptoms in 30-50% of women and are the leading cause of hysterectomy in the United States. Women with uterine fibroid tumors often seek uterine-preserving treatments, but c…

nonrandomized-trial 2019
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13632

INTRODUCTION: Adenomyosis is a benign uterine disease where endometrial glands and stroma are found within the myometrium surrounded by an area of hypertrophic myometrium. Symptomatology includes heavy menstrual bleeding and pelvic pain. Th…

rct 2017
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2016.12.177

BACKGROUND: Uterine fibroids are a common problem for reproductive-aged women, yet little comparative effectiveness research is available to guide treatment choice. Uterine artery embolization and magnetic resonance imaging-guided focused u…

rct 2016
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2016.04.001

BACKGROUND: Uterine fibroids are an important source of morbidity for reproductive-aged women. Despite an increasing number of alternatives, hysterectomies account for about 75% of all fibroid interventional treatments. Evidence is lacking …